Stock data
Traws Pharma, Inc. (TRAW)
Traws Pharma, Inc. (TRAW) reported revenue of US$2.79M and net income of US$9.17M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$2.79M | — | -US$17.88M | US$9.17M | — |
| 2024 | US$0.23M | — | -US$142.37M | -US$166.52M | — |
| 2023 | US$0.23M | — | -US$20.30M | -US$18.95M | — |
| 2022 | US$0.23M | — | -US$19.63M | -US$18.96M | — |
| 2021 | US$0.23M | — | -US$16.50M | -US$16.16M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.05M | — |
| 2026-03-31 | — | -US$7.11M | — |
| 2025-12-31 | — | -US$7.44M | — |
| 2025-09-30 | — | -US$3.96M | — |
| 2025-06-30 | US$2.73M | -US$0.92M | — |
| 2025-03-31 | US$0.06M | US$21.49M | — |
| 2024-12-31 | US$0.06M | -US$29.92M | — |
| 2024-09-30 | US$0.06M | -US$8.47M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.